| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e649fb2f20f0f34618a40c0bc5fdfba0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-193 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 |
| filingDate |
2008-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_843d9a80e2706c175342f7429763b254
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96e5c4df7013276283cb66e6941cb563
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d305c5ce93959dcdb42c42644099230
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff3d6aa2c4841ab8a987c59869ef1bf6 |
| publicationDate |
2010-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010284926-A1 |
| titleOfInvention |
Use of g-csf for the treatment of stroke |
| abstract |
The invention relates to the use of G-CSF for the treatment of cerebral stroke, particularly cerebral stroke with a large baseline infarct volume. Administration of G-CSF at a total dose of 30 to 180 μg per kg body weight over a treatment period of about 3 days is suitable for the treatment of stroke. Treatment in accordance with the invention with a total dose of 80 to 150 μg per kg body weight is preferred. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8071543-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008279814-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009087481-A1 |
| priorityDate |
2007-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |